Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meyers, S. P.
Right arrow Articles by Sen, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meyers, S. P.
Right arrow Articles by Sen, C.

Radiology, Vol 184, 103-108, Copyright © 1992 by Radiological Society of North America

ARTICLES

Chondrosarcomas of the skull base: MR imaging features

SP Meyers, WL Hirsch Jr, HD Curtin, L Barnes, LN Sekhar and C Sen
Department of Radiology, University of Pittsburgh School of Medicine, Presbyterian-University Hospital, PA 15213.

The magnetic resonance (MR) images from 17 patients with chondrosarcomas of the skull base were retrospectively reviewed to characterize the size, location, signal intensity, and extension of these tumors. Eleven patients with chondrosarcomas received intravenously administered gadopentetate dimeglumine. In 16 patients, computed tomographic (CT) scans were obtained to evaluate intratumorous mineralization and bone erosion. On short repetition time (TR)/echo time (TE) MR images, chondrosarcomas generally had low to intermediate signal intensity; on long TR/TE MR images, they generally had very high signal intensity. Signal heterogeneity on long TR/TE MR images was seen in 10 of 17 tumors (59%) and was caused by matrix mineralization, fibrocartilaginous elements, or both. Matrix mineralization was demonstrated with CT in seven of the 16 chondrosarcomas. Chondrosarcomas showed marked enhancement after administration of gadopentetate dimeglumine in either a heterogeneous (n = 8) or homogeneous (n = 3) pattern. The information about the size and extent of these neoplasms was important in the choice of surgical approaches for gross total resection of tumor.


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
C. A. Allan, G. Kaltsas, J. Evanson, J. Geddes, D. G. Lowe, P. N. Plowman, and A. B. Grossman
Pituitary Chondrosarcoma: An Unusual Cause of a Sellar Mass Presenting as a Pituitary Adenoma
J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 386 - 391.
[Abstract] [Full Text]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
A. G G C Korten, H. J W ter Berg, G. H Spincemaille, R. T van der Laan, and A. M Van de Wel
Intracranial chondrosarcoma: review of the literature and report of 15 cases
J. Neurol. Neurosurg. Psychiatry, July 1, 1998; 65(1): 88 - 92.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1992 by the Radiological Society of North America.